1 asset in Pituitary Stalk Interruption Syndrome
Therapeutic assets addressing Pituitary Stalk Interruption Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Setmelanotide Pituitary Stalk Interruption Syndrome | Rhythm Pharmaceuticals, Inc. | P3 | B (60) |